Rc705-779 - Open Access .click

Results 11 to 20 of about 71,360 (115)

Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779-5

, 2011
Copyright information:Taken from "Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779"http://www.biomedcentral.com/1471-2210/7/14BMC ...
Laifong Lee (43397) +3 more
core +1 more source

Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779-2

, 2011
Copyright information:Taken from "Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779"http://www.biomedcentral.com/1471-2210/7/14BMC ...
Laifong Lee (43397) +3 more
core +1 more source

Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779-1

, 2011
Copyright information:Taken from "Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779"http://www.biomedcentral.com/1471-2210/7/14BMC ...
Laifong Lee (43397) +3 more
core +1 more source

ANL-W 779 pond seepage test [PDF]

, 1992
The ANL-W 779 sanitary wastewater treatment ponds are located on the Idaho National Engineering Laboratory (INEL), north of the Argonne National Laboratory -- West (ANL-W) site A seepage test was performed for two Argonne National Laboratory -- West (ANL-
Braun, D. R.
core +3 more sources

Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779-6

, 2011
Copyright information:Taken from "Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779"http://www.biomedcentral.com/1471-2210/7/14BMC ...
Laifong Lee (43397) +3 more
core +1 more source

Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779-0

, 2011
Copyright information:Taken from "Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779"http://www.biomedcentral.com/1471-2210/7/14BMC ...
Laifong Lee (43397) +3 more
core +1 more source

Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779-7

, 2011
Copyright information:Taken from "Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779"http://www.biomedcentral.com/1471-2210/7/14BMC ...
Laifong Lee (43397) +3 more
core +1 more source

Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779-3

, 2011
Copyright information:Taken from "Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779"http://www.biomedcentral.com/1471-2210/7/14BMC ...
Laifong Lee (43397) +3 more
core +1 more source

Medicine [779]

, 2021
Medicine. This manuscript is now IO Islamic 854 in the India Office collections. [metadata: Otto Loth, A Catalogue of the Arabic Manuscripts in the Library of the India Office, (volume 1), no. 779 here with further notations and hyperlinks].
ḲUṬB AL-DÎN MAḤMÛD b. Mas'ûd b. Muṣliḥ SHÎRÂZÎ
core +1 more source

Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779-4

, 2011
Copyright information:Taken from "Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779"http://www.biomedcentral.com/1471-2210/7/14BMC ...
Laifong Lee (43397) +3 more
core +1 more source

diseases of the respiratory system
copd
acute respiratory distress syndrome

chronic obstructive pulmonary disease